60 research outputs found
RECURRENT PREGNANCY LOSS IS ASSSOCIATED TO LEAKY GUT: A NOVEL PATHOGENIC MODEL OF ENDOMETRIUM INFLAMMATION ?
Background: Recurrent pregnancy loss (RPL) occurs in 3\u20135% in about 30% of cases no cause can be found. Women
with RPL show higher prevalence of undiagnosed gut disorders. Furthermore, in endometrial tissues of RPL women,
higher expression of pro-inflammatory cytokines and Nalp-3 inflammasome has been observed. Aim of this study was
to investigate whether an abnormal gut permeability might occur in RPL women and allow passage into systemic
circulation of pro-inflammatory molecules able to induce endometrial inflammation.
Methods: 70 women with idiopathic RPL and 30 healthy women were recruited at the Recurrent Pregnancy Loss
Outpatient Unit of the Gemelli Hospital of Rome from March 2013 to February 2017. Enrolled women underwent
51Cr-ethylene-diamine-tetraacetic acid absorption test to evaluate intestinal permeability. Sera obtained from enrolled
women were analysed for lipopolysaccharide (LPS) by ELISA. Anxiety and depression state were evaluated by administering
STAI-Y and Zung-SDS tests, respectively. Of all recruited individuals, 35 women with idiopathic RPL and 20
healthy controls accepted to undergo diagnostic hysteroscopy and endometrial biopsy. Endometrial lysates were
investigated for inflammasome Nalp-3 by Western blot analysis, and caspase-1, IL-1\u3b2 and IL-18 by ELISA, respectively.
Results: Higher prevalence of abnormal intestinal permeability (P < 0.0001), increased circulating levels of LPS
(P < 0.05), anxiety (P < 0.05) and depression (P < 0.05) were observed in RLP women compared to controls. Endometrial
expression of Nalp-3, caspase-1 and IL-1\u3b2 was significantly increased in RPL group (P < 0.0001; P < 0.05 and P < 0.001,
respectively). IL-18 endometrial levels were not found to be higher in RPL cases. Statistically significant association
between higher intestinal permeability and abnormally increased expression of endometrial Nalp-3, was observed in
RPL (P < 0.01). Furthermore, higher LPS serum levels, a bacterial-derived activator of Nalp-3 complex, was shown to be
statistically associated to abnormal endometrial expression of Nalp-3 inflammasome (P < 0.01) in RPL women.
Conclusions: In women with RLP, leaky gut might occur and allow passage into circulation of immune triggers,
potentially able to elicit endometrial innate immune response and, thus, to contribute to miscarriage pathogenesis.
Diagnosis and treatment of intestinal disorders underlying leaky gut might improve endometrial environment and
pregnancy outcome
Effect of Low Molecular Weight Heparins (LMWHs) on antiphospholipid Antibodies (aPL)-mediated inhibition of endometrial angiogenesis
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by vascular thrombosis and/or pregnancy morbidity in the presence of circulating antiphospholipid antibodies (aPL). Different pathogenic mechanisms for aPL-mediated pregnancy failure have been proposed. In particular a direct effect of aPL on both maternal and fetal side of the placental tissue has been reported, since their reactivity with \u3b22-glycoprotein I (\u3b22GPI) makes them adhere to trophoblast and human endometrial endothelial cell (HEEC) membranes. \u3b22GPI can be recognized by aPL that, once bound, interfere with both trophoblast functions and with the HEEC differentiation.APS patients can be successfully treated with Low Molecular Weight Heparin (LMWH). Recent reports suggest that LMWH acts through mechanisms alternative to its well known anticoagulant effect, because of its ability to bind \u3b22GPI. In our previous studies, we showed that LMWH is able to reduce the aPL binding to trophoblasts and restore cell invasiveness and differentiation. So far, however, no study has described its effects on endometrial angiogenesis.The aim of our research was to evaluate whether two LMWHs, tinzaparin and enoxaparin, have an effect on the aPL-inhibited endometrial angiogenesis. This prompted us to investigate: (i) in vitro HEEC angiogenesis through a Matrigel assay; (ii) VEGF secretion by ELISA; (iii) matrix metalloproteinase-2 (MMP-2) activity by gelatin zymography; (iv) Nuclear Factor-\u3baB (NF-\u3baB) DNA binding activity by colorimetric assay; (v) STAT-3 activation by a sandwich-ELISA kit. Furthermore, using an in vivo murine model we investigated the LMWHs effects on angiogenesis.We demonstrated that the addition of LMWHs prevents aPL-inhibited HEEC angiogenesis, both in vitro and in vivo, and is able to restore the aPL inhibited NF-\u3baB and/or STAT-3 activity, the VEGF secretion and the MMPs activity.The demonstration of a beneficial role for LMWHs on the aPL-inhibited HEEC angiogenesis might provide additional mechanisms whereby this treatment protects early pregnancy in AP
Correction to: Recurrent pregnancy loss is associated to leaky gut: a novel pathogenic model of endometrium inflammation?
Background: Recurrent pregnancy loss (RPL) occurs in 3–5% in about 30% of cases no cause can be found. Women
with RPL show higher prevalence of undiagnosed gut disorders. Furthermore, in endometrial tissues of RPL women,
higher expression of pro-inflammatory cytokines and Nalp-3 inflammasome has been observed. Aim of this study was
to investigate whether an abnormal gut permeability might occur in RPL women and allow passage into systemic
circulation of pro-inflammatory molecules able to induce endometrial inflammation.
Methods: 70 women with idiopathic RPL and 30 healthy women were recruited at the Recurrent Pregnancy Loss
Outpatient Unit of the Gemelli Hospital of Rome from March 2013 to February 2017. Enrolled women underwent
51Cr-ethylene-diamine-tetraacetic acid absorption test to evaluate intestinal permeability. Sera obtained from enrolled
women were analysed for lipopolysaccharide (LPS) by ELISA. Anxiety and depression state were evaluated by administering
STAI-Y and Zung-SDS tests, respectively. Of all recruited individuals, 35 women with idiopathic RPL and 20
healthy controls accepted to undergo diagnostic hysteroscopy and endometrial biopsy. Endometrial lysates were
investigated for inflammasome Nalp-3 by Western blot analysis, and caspase-1, IL-1β and IL-18 by ELISA, respectively.
Results: Higher prevalence of abnormal intestinal permeability (P < 0.0001), increased circulating levels of LPS
(P < 0.05), anxiety (P < 0.05) and depression (P < 0.05) were observed in RLP women compared to controls. Endometrial
expression of Nalp-3, caspase-1 and IL-1β was significantly increased in RPL group (P < 0.0001; P < 0.05 and P < 0.001,
respectively). IL-18 endometrial levels were not found to be higher in RPL cases. Statistically significant association
between higher intestinal permeability and abnormally increased expression of endometrial Nalp-3, was observed in
RPL (P < 0.01). Furthermore, higher LPS serum levels, a bacterial-derived activator of Nalp-3 complex, was shown to be
statistically associated to abnormal endometrial expression of Nalp-3 inflammasome (P < 0.01) in RPL women.
Conclusions: In women with RLP, leaky gut might occur and allow passage into circulation of immune triggers,
potentially able to elicit endometrial innate immune response and, thus, to contribute to miscarriage pathogenesis.
Diagnosis and treatment of intestinal disorders underlying leaky gut might improve endometrial environment and
pregnancy outcome
Dalla \u39a\u3b9\u3bc\u3c9\u3bb\u3b9\u3b1 \u3b3\u3b7 a \u39a\u3b9\u3bc\u3c9\u3bb\u3bf\u3c3. il progetto di ricerca \u2018\u39a\u3b9\u3bc\u3c9\u3bb\u3b9\u3b1 \u3b3\u3b7\u2019 (KERP)
DETERMINAZIONE DELLA FARMACORESISTENZA DI HIV-1 MEDIANTE ANALISI GENOTIPICA: CONFRONTO SULLA PREDITTIVITĂ€ DEI SAGGI INTERPRETATIVI VIROSEQ TM HIV-1 (APPLIED BIOSYSTEM), HIVSEQ (STANFORD) E VIRTUAL PHENOTYPE (VIRCONET TM).
α-Lipoic Acid and its Role on Female Reproduction
alpha-lipoic Acid (ALA), also known as thioctic acid, is a biological thiol present in all types of prokaryotic and eukaryotic cells. It has been shown that ALA or its reduced form, DHLA, has several positive effects on human health, acting as a biological antioxidant, metal chelator and detoxifying agent. It is able to reduce the oxidation of several antioxidant agents like glutathione, vitamins C and E, and modulate insulin and NF-kB signaling pathways. ALA's pharmacological effects are not only related to its antioxidant properties but it shows an anti-inflammatory action. In particular, ALA is able to reduce inflammasome activity, the pro-inflammatory cytokine levels, such as TNF-alpha, IL-1 beta, IL-6, IL-18 and IL-17, interferon (INF)-gamma as well as the production of Vascular and Intercellular cell adhesion protein (VCAM-1 and ICAM-1). In recent papers, ALA has been indicated as a possible therapeutic approach to several endocrine or inflammatory disorders affecting female reproduction. Aim of the current review was to assess whether ALA has an evidence-based beneficial role on gynecological and obstetrical diseases such as polycystic ovary syndrome (PCOS), endometriosis, and miscarriage
ENCEFALITI DA VIRUS ERPETICI IN SOGGETTI IMMUNOCOMPETENTI: DIAGNOSI CON TEST DI PCR SU LIQUOR
- …